Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oleoyl-estrone is a naturally occurring fatty acid ester of estrone, found in the plasma and adipose tissue of animals and humans. It has been investigated as an anti-obesity agent due to its ability in animal studies to promote loss of body fat while preserving lean body mass and maintaining nitrogen balance. Mechanistically, it acts both centrally—by resetting the hypothalamic "ponderostat" (the brain's food control center) to reduce appetite and energy intake—and peripherally—by reducing fat storage in white adipose tissue and promoting skeletal muscle utilization of fat for energy. Oleoyl-estrone also appears to spare protein stores during weight loss, maintain glycemia with lower insulin levels, increase cholesterol catabolism, inhibit lipid synthesis in adipose tissue, and inhibit 17β-hydroxysteroid dehydrogenase (reducing β‑estradiol and testosterone synthesis). Clinical trials have not demonstrated significant efficacy for weight loss compared to placebo[1][2][5][7][8][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on oleoyl-estrone.